Market closedNon-fractional

Edgewise Therapeutics/EWTX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Edgewise Therapeutics

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.

Ticker

EWTX

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Boulder, United States

Employees

92

EWTX Metrics

BasicAdvanced
$2B
Market cap
-
P/E ratio
-$1.52
EPS
0.16
Beta
-
Dividend rate
$2B
0.16
37.084
36.49
0.797
0.981
-17.14%
-24.51%
3.71
3.71
-14.874
14.53%
-57.81%

What the Analysts think about EWTX

Analyst Ratings

Majority rating from 6 analysts.
Buy

EWTX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$29M
-5.32%
Profit margin
0.00%
NaN%

EWTX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 15.82%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.34
-$0.41
-$0.47
-$0.33
-
Expected
-$0.40
-$0.40
-$0.43
-$0.39
-$0.35
Surprise
-14.57%
3.54%
8.29%
-15.82%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Edgewise Therapeutics stock?

Edgewise Therapeutics (EWTX) has a market cap of $2B as of July 25, 2024.

What is the P/E ratio for Edgewise Therapeutics stock?

The price to earnings (P/E) ratio for Edgewise Therapeutics (EWTX) stock is 0 as of July 25, 2024.

Does Edgewise Therapeutics stock pay dividends?

No, Edgewise Therapeutics (EWTX) stock does not pay dividends to its shareholders as of July 25, 2024.

When is the next Edgewise Therapeutics dividend payment date?

Edgewise Therapeutics (EWTX) stock does not pay dividends to its shareholders.

What is the beta indicator for Edgewise Therapeutics?

Edgewise Therapeutics (EWTX) has a beta rating of 0.16. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Edgewise Therapeutics stock

Buy or sell Edgewise Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing